drugset / Trial / NCT05492851
Trial Comparing Three Single Dose Injections for Knee Osteoarthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a 3-arm, double-blind, randomized trial comparing the clinical outcomes of Zilretta, Synvisc One, and Monovisc for knee OA.
Timeline
- Start
- 2022-08-02
- Primary completion
- 2023-01-11
- Completion
- 2023-01-11
Outcome
Outcome not reported
Stopped (Enrollment): “The study has only enrolled 6 subjects in 6 months since study initiation. Potential participants are unwilling to participate in the study due to the randomziation and blinding. Both aspects are needed to ensure a robust comparison between groups.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hyaluronan | Other / unclassified | 88 mg | Other |
| Comparator | Hylan G-F 20 | Other / unclassified | 48 mg | Other |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 32 mg | Other |